Health and Fitness Health and Fitness
Thu, February 9, 2012
[ Thu, Feb 09th 2012 ] - Market Wire
Johnson & Johnson to Participate in 2012 Leerink Swann Global Health Care Conference
[ Thu, Feb 09th 2012 ] - Market Wire
Johnson amp;; Johnson to Participate in 2012 Leerink Swann Global Health Care Conference
[ Thu, Feb 09th 2012 ] - Market Wire
Faruqi & Faruqi, LLP Announces Investigation of Columbia Laboratories Inc.
[ Thu, Feb 09th 2012 ] - Market Wire
Mesa Laboratories to Present at the RedChip Small-Cap Equities Virtual Conference
[ Thu, Feb 09th 2012 ] - Market Wire
Luminex Corporation to Present at Upcoming Investment Conferences in February and March
[ Thu, Feb 09th 2012 ] - Market Wire
Faruqi amp;; Faruqi, LLP Announces Investigation of Columbia Laboratories Inc.
[ Thu, Feb 09th 2012 ] - Market Wire
Mylan CEO Heather Bresch Testifies Before Congres .. User Fee Program and Urges Update of Federal Food
[ Thu, Feb 09th 2012 ] - Market Wire
Amgen, Montpelier Re Holdings, Cisco Systems, Illumina and Roche Holdings
[ Thu, Feb 09th 2012 ] - Market Wire
A Forward Look, the Year Ahead - Featured Researc .. n Acorda Therapeutics Inc and Abbott Laboratories
[ Thu, Feb 09th 2012 ] - Market Wire
A Forward Look, the Year Ahead - Featured Researc .. rmaceutical Inc. and Amylin Pharmaceuticals, Inc.
[ Thu, Feb 09th 2012 ] - Market Wire
Perception, Opportunity in Volatility - Research .. is on VIVUS, Inc. and Eli Lilly &;; Co.
[ Thu, Feb 09th 2012 ] - Market Wire
Notice of Paladin Labs' Fourth Quarter 2011 Results Conference Call
[ Thu, Feb 09th 2012 ] - Market Wire
Results From Phase I Clinical Trials Demonstrate .. ioPharma's RNA-Based Therapeutics for Treatment o
[ Thu, Feb 09th 2012 ] - Market Wire
SeraCare Expands Infectious Disease Offerings with Six New Product Introductions
[ Thu, Feb 09th 2012 ] - Market Wire
Instituto de Radioterapia del Este in Humacao, Pu .. r Patients Fast, Precise Radiotherapy Using Trilo
[ Thu, Feb 09th 2012 ] - Market Wire
Orexigen Therapeutics to Present at Upcoming Conferences
[ Thu, Feb 09th 2012 ] - Market Wire
Volcano Corporation Schedules Fourth Quarter Conference Call, Webcast
[ Thu, Feb 09th 2012 ] - Market Wire
Inergetics Announces the Launch of its Private La .. ply Agreement with Muscle Maker Grill Restaurants
[ Thu, Feb 09th 2012 ] - Market Wire
West to Host Fourth Quarter and Full Year 2011 Conference Call
[ Thu, Feb 09th 2012 ] - Market Wire
Mylan Receives Final FDA Approval for First Generic Version of Doryx Tablets, 150 mg
[ Thu, Feb 09th 2012 ] - Market Wire
Palatin Technologies to Present at 14th Annual BIO CEO amp;; Investor Conference
[ Thu, Feb 09th 2012 ] - Market Wire
Auxilium Pharmaceuticals to Announce Fourth Quart .. ct Conference Call on Thursday, February 23, 2012
[ Thu, Feb 09th 2012 ] - Market Wire
Delcath to Present at the 14th Annual BIO CEO amp;; Investor Conference on February 14
[ Thu, Feb 09th 2012 ] - Market Wire
Delcath to Present at the 14th Annual BIO CEO & Investor Conference on February 14
Wed, February 8, 2012
[ Wed, Feb 08th 2012 ] - Market Wire
Basilea Reports 2011 Financials With Better Than Expected Operating Results
[ Wed, Feb 08th 2012 ] - Market Wire
MannKind Announces Exercise In Full of Over-Allot .. Public Offering of Units Consisting of Common St
[ Wed, Feb 08th 2012 ] - Market Wire
Forest Laboratories Inc. and Gedeon Richter Plc A .. sults with the Investigational Antipsychotic Cari
[ Wed, Feb 08th 2012 ] - Market Wire
Thomas E. Shenk To Retire From Merck's Board of Directors
[ Wed, Feb 08th 2012 ] - Market Wire
Array BioPharma Announces Proposed Public Offering of Common Stock
[ Wed, Feb 08th 2012 ] - Market Wire
Affymax to Present at 14th Annual BIO CEO & Investor Conference

Affymax to Present at 14th Annual BIO CEO & Investor Conference


Published on 2012-02-08 21:42:41 - Market Wire
  Print publication without navigation


PALO ALTO, Calif.--([ ])--Affymax, Inc. (Nasdaq: AFFY) today announced that John Orwin, the companyas chief executive officer, will present at the 14th Annual BIO CEO & Investor Conference on Tuesday, February 14, 2012 at 3:00 p.m. Eastern Time in New York City.

A live webcast of the presentation will be available on the investors section of the Company's website at [ www.affymax.com ]. A replay will also be available for 30 days following the presentation.

About Affymax, Inc.

Affymax, Inc. is a biopharmaceutical company committed to developing novel drugs to improve the treatment of serious and often life-threatening conditions. For additional information, please visit [ www.affymax.com ].

Contributing Sources